Novavax
NVAX
142 hedge funds and large institutions have $77.8M invested in Novavax in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 52 increasing their positions, 36 reducing their positions, and 46 closing their positions.
304% more call options, than puts
Call options by funds: $28.6M | Put options by funds: $7.08M
44% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 36
0.47% less ownership
Funds ownership: 2.06% → 1.6% (-0.47%)
15% less funds holding
Funds holding: 168 → 142 (-26)
57% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 46
73% less capital invested
Capital invested by funds: $290M → $77.8M (-$213M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.94M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$6.9M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.72M |
| 4 |
Renaissance Technologies
New York
|
+$3.15M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$10.9M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$8.68M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$8.63M |
| 4 |
JP Morgan Chase
New York
|
-$8.29M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.52M |
NVAX Hedge Fund Activity: Q1 2019 in Review
142 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2019, worth a combined $77.8M — down 73% from $290M a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of NVAX and 20 opened new positions — a net loss of 26 holders — while 36 trimmed existing stakes and 52 added.
The largest buyer was Vanguard Group, adding an estimated $7.94M. The largest seller was State Street, cutting an estimated $10.9M.
- 142 institutional investors held Novavax (NVAX) as of Q1 2019, down from 168 in Q4 2018.
- Funds reported $77.8M of Novavax stock for Q1 2019, down 73% quarter-over-quarter.
- 20 funds opened new Novavax positions in Q1 2019 and 46 closed out, a net change of -26 holders.
- The largest Novavax buyer in Q1 2019 was Vanguard Group, an estimated $7.94M added.
- The largest Novavax seller in Q1 2019 was State Street, an estimated $10.9M sold.
Based on aggregated 13F filings for Q1 2019.